Skip to content

Clinical trials

Completed Coronary Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Status: Completed Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20083
20093
20101
20111
20123
20142
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices7
GlaxoSmithKline2
Hoffmann-La Roche2
Amarin Pharma Inc.1
Amgen1
AstraZeneca1
Bayside Health1
Glycemic Index Laboratories, Inc1
Indication Bioscience LLC1
Medtronic Vascular1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease23
Coronary Artery Disease11
Myocardial Ischemia9
Coronary Stenosis8
Cardiovascular Diseases7
Coronary Restenosis7
Heart Diseases4
Vascular Diseases4
Atherosclerosis3
Dyslipidemias3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.